Differential Impact of Degree of Hypertension on Subclinical Coronary Atherosclerosis in Asymptomatic Subjects With and Without Diabetes Mellitus

• Published in: The American journal of cardiology Vol. 203; pp. 343 - 351
• Main Authors: Park, Hyun Woo, Jo, Sangyong, Park, Kyung Sun, Lee, Hyeji, Jeon, Young-Jee, Park, Sangwoo, Ann, Soe Hee, Kim, Yong-Giun, Choi, Seong Hoon, Kwon, Woon Jung, Cho, Young-Rak, Suh, Jon, Park, Gyung-Min
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15.09.2023; Elsevier Limited
• Subjects: Angina pectoris; Angiography; Angioplasty; Arteriosclerosis; Asymptomatic; Atherosclerosis; Blood pressure; Body mass index; Calcification; Cardiology; Cardiovascular disease; Cardiovascular diseases; Cholesterol; Computed tomography; Coronary artery disease; Coronary vessels; Creatinine; Diabetes; Diabetes mellitus; Electrocardiography; Family medical history; Heart attacks; Heart diseases; Heart surgery; Hemoglobin; Hospitals; Hyperlipidemia; Hypertension; Medical records; Questionnaires; Regression analysis; Risk factors; Statistical analysis; Tomography
• ISSN: 0002-9149; 1879-1913; 1879-1913
• DOI: 10.1016/j.amjcard.2023.07.036

This study sought to evaluate the association between the degree of hypertension and subclinical coronary atherosclerosis in asymptomatic subjects with and without diabetes mellitus (DM). We retrospectively analyzed 7,352 asymptomatic subjects (mean age 52.8 ± 7.8 years; 4,689 [63.8%] men) with no history of coronary artery disease who voluntarily underwent coronary computed tomography angiography as part of a general health examination. The classification of hypertension was adapted from the American College of Cardiology and American Heart Association 2017 guideline. Subclinical coronary atherosclerosis was defined as the presence of coronary plaque by coronary computed tomography angiography. In subjects without DM (n = 6,598), after the adjustment for cardiovascular risk factors, subclinical coronary atherosclerosis was significantly associated with both stage 1 hypertension (adjusted odds ratio [aOR] 1.356; 95% confidence interval [CI], 1.167 to 1.575; p <0.001) and stage 2 hypertension (aOR, 1.614; 95% CI, 1.329 to 1.961; p <0.001) groups compared with the normal group. In contrast, in subjects with DM (n = 754), there was no statistical difference in the aOR of the stage 1 hypertension group for the presence of coronary plaque (aOR, 1.449; 95% CI, 0.982 to 2.136; p = 0.061). However, the stage 2 hypertension group had a significant association with subclinical coronary atherosclerosis (aOR, 2.067; 95% CI, 1.287 to 3.322; p = 0.003). In subjects without DM, both stages 1 and 2 hypertension were associated with subclinical coronary atherosclerosis. However, in subjects with DM, stage 2 hypertension was only associated with an increased risk of subclinical coronary atherosclerosis.